Your session is about to expire
← Back to Search
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer (PCW Trial)
N/A
Waitlist Available
Led By Joanne Sandberg
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline up to 3 months after treatment completion
Awards & highlights
No Placebo-Only Group
Summary
The objective of this study is to examine how adenocarcinoma of the prostate treatment differentially affects African American men's ability to work and to describe and compare changes in work ability (as measured through self-reported global work ability item) reported by African American and white adenocarcinoma of the prostate survivors before treatment and 6 months after treatment completion.
Eligible Conditions
- Prostate Cancer
- Prostate Adenocarcinoma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from baseline to 3 months after treatment completion
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to 3 months after treatment completion
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in work ability measured by Global Work Ability
Secondary study objectives
Difference between preferred and actual length of leave
Trajectory of change in work ability at 3 months measured by Global Work Ability
Trajectory of change in work ability at 3 months measured by Work Limitations Questionnaire (WLQ)
+4 moreOther study objectives
Effect of race and income on treatment-related function, work environment, and type of treatment
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Group I: Race: Non-Hispanic WhiteExperimental Treatment2 Interventions
Patients undergo an interview over 40-60 minutes at baseline and 3 and 6 months after treatment to describe and compare changes in ability to work and employment status/income.
Group II: Race: Non-Hispanic African AmericanExperimental Treatment2 Interventions
Patients undergo an interview over 40-60 minutes at baseline and 3 and 6 months after treatment to describe and compare changes in ability to work and employment status/income.
Group III: Income: Lower IncomeExperimental Treatment2 Interventions
Patients undergo an interview over 40-60 minutes at baseline and 3 and 6 months after treatment to describe and compare changes in ability to work and employment status/income.
Group IV: Income: Higher IncomeExperimental Treatment2 Interventions
Patients undergo an interview over 40-60 minutes at baseline and 3 and 6 months after treatment to describe and compare changes in ability to work and employment status/income.
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,403 Previous Clinical Trials
2,478,080 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,958 Previous Clinical Trials
41,112,325 Total Patients Enrolled
Joanne SandbergPrincipal InvestigatorWake Forest University Health Sciences